Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Prognostic Implications of SMARCA4, ARID1A, and Other BAF Mutations in Non-Small Cell Lung Cancer.
Journal: Cancer medicine
Published: July 08, 2025
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 21, 2024
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 21, 2024
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results.
Journal: Nature medicine
Published: January 03, 2023
GPRC5D-Targeted CAR T Cells for Myeloma.
Journal: The New England journal of medicine
Published: December 14, 2022
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 28, 2021
Idecabtagene Vicleucel in Relapsed Myeloma.
Journal: The New England journal of medicine
Published: June 16, 2021
CAR-Transduced Natural Killer Cells.
Journal: The New England journal of medicine
Published: May 07, 2020
Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma.
Journal: The New England journal of medicine
Published: July 18, 2019
CD19 directed CARs in acute lymphoblastic leukemia: state of the art and beyond.
Journal: Leukemia & lymphoma
Published: January 17, 2019
Last Updated: 09/26/2026